Concepedia

Yoshi Ichikawa

YI

Statistics

Publications

8

Citations

256

H-Index

8

Active since

2002

Affiliations

Edimer Pharmaceuticals (United States)(Current)

Singapore Science Park

Johns Hopkins University

Yoshi Ichikawa is an author at Edimer Pharmaceuticals (United States) specializing in medicine, natural sciences, and biochemistry.

Top concepts

MedicineBiochemistryNatural SciencesPharmacologyDrug DiscoveryMicrobiologyMolecular BiologyBioorganic ChemistryImmunologyEngineering

Publications per year

2002–2014

8

Publications

8

Mechanism of the <i>Escherichia coli</i> ADP-Ribose Pyrophosphatase, a Nudix Hydrolase<sup>,</sup>

Sandra B. Gabelli, Mario A. Bianchet, Yuki Ohnishi et al. · Biochemistry · 2002 · 67 citations

Biosynthesis, Biochemistry, Bioenergetics +11

Synthesis of sialyl Lewisa (sLea, CA19-9) and construction of an immunogenic sLea vaccine

Govind Ragupathi, Payal Damani, Geeta Srivastava et al. · Cancer Immunology Immunotherapy · 2009 · 52 citations

Vaccination, Immunogenic Slea Vaccine, Engineering +10

Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics

Chang‐Hsing Liang, Sulan Yao, Yu-Hung Chiu et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 38 citations

Biological Activity, Bioorganic Chemistry, Biochemistry +8

An efficient entry to new sugar modified ketolide antibiotics

Alex Romero, Chang‐Hsing Liang, Yu-Hung Chiu et al. · Tetrahedron Letters · 2005 · 35 citations

Medicine, New Sugar, Antimicrobial Chemotherapy +4

Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum

Hon Wai Koon, Samantha Ho, Tressia Hing et al. · Antimicrobial Agents and Chemotherapy · 2014 · 19 citations · Full text

1–5 of 8